In 2023, Japan's share of drug discovery publications within the top 10% globally was a significant metric tracked, setting the baseline for future projections. Forecasts from 2024 to 2028 show a slight declining trend in this share, starting at 4.11% in 2024 and gradually decreasing to 4.06% by 2028. The year-on-year variation shows a minor but steady decline over the period, averaging a very small negative compound annual growth rate (CAGR) near zero during these years, indicating a stagnation in Japan's influence in this sector.
Future trends to watch for include Japan's strategic investments in innovation and collaboration with international research institutions. Such measures could potentially reverse the slowing trend, enhancing Japan's impact in cutting-edge scientific developments. Monitoring policy changes and funding allocations will be critical to assessing future Science and Technology outputs from Japan.
